Free National NPI Number Registry

Dr. Peter Bryan Boggs

Home >Dr. Peter Bryan Boggs

 

NPI Number Detailed Information

Provider Information:

Name: Dr. Peter Bryan Boggs
Gender: M
Provider License Number If Given: 9735

NPI Information:

NPI: 1447217252
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 4/26/2006

Last Update Date: 6/18/2021

Reputation Report:

Provider Business Mailing Address:

Address: 2300 HOSPITAL DR STE 345
Bossier City, LA 71111
Phone Number: 3182127808
Fax Number: 3182127348

Provider Business Practice Location Address:

Address: 2300 HOSPITAL DR STE 345
Bossier City, LA 71111
Phone Number: 3182127808
Fax Number: 3182127348

Provider Taxonomy:

Primary: 207KI0005X
Secondary (if any):
State: LA

Top Doctors in LA

 

About Dr. Peter Bryan Boggs

Dr. Peter Bryan Boggs (DR. PETER BRYAN BOGGS ) is Definition Allergy & Immunology Physician in Bossier City, LA. The NPI Number for Dr. Peter Bryan Boggs is 1447217252.
The current location address for Dr. Peter Bryan Boggs is 2300 HOSPITAL DR STE 345 Bossier City, LA 71111 and the contact number is 3182127808 and fax number is 3182127348. The mailing address for Dr. Peter Bryan Boggs is 2300 HOSPITAL DR STE 345 Bossier City, LA 71111- 3182127808 (mailing address contact number - 3182127808).
Definition to come...

Provider Business Location on Map

FAQs:

What is the NPI Number for Dr. Peter Bryan Boggs ?


Answer: The NPI Number for Dr. Peter Bryan Boggs is 1447217252

Where is Dr. Peter Bryan Boggs located?


Answer: Dr. Peter Bryan Boggs is located at 2300 HOSPITAL DR STE 345 Bossier City, LA 71111.

What is the specialty for Dr. Peter Bryan Boggs ?


Answer: The Specialty of Dr. Peter Bryan Boggs is Definition Allergy & Immunology Physician.

Are there any online reviews for Dr. Peter Bryan Boggs ?


Answer: Yes! Check It Now.

Are there any other health care providers in Bossier City, LA?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Peter Bryan Boggs

Number of HCPCS 20
Number of Medicare Beneficiaries 129
Number of Services 866
Total Submitted Charge Amount 75446
Total Medicare Allowed Amount 41096.55
Total Medicare Payment Amount 29007.46
Total Medicare Standardized Payment Amount 30277.34
Drug Suppress Indicator *
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator #
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries 73
Number of Beneficiaries Age Less 65 13
Number of Beneficiaries Age 65 to 74 60
Number of Beneficiaries Age 75 to 84 43
Number of Beneficiaries Age Greater 84 13
Number of Female Beneficiaries 89
Number of Male Beneficiaries 40
Number of Non-Hispanic White Beneficiaries 98
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement 18
Number of Beneficiaries With Medicare Only Entitlement 111
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.09
Percent (%) of Beneficiaries Identified With Asthma 0.28
Percent (%) of Beneficiaries Identified With Cancer
Percent (%) of Beneficiaries Identified With Heart Failure 0.12
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.19
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.17
Percent (%) of Beneficiaries Identified With Depression 0.18
Percent (%) of Beneficiaries Identified With Diabetes 0.21
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.57
Percent (%) of Beneficiaries Identified With Hypertension 0.74
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.36
Percent (%) of Beneficiaries Identified With Osteoporosis 0.16
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.57
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries 0.9623

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Allergy/ Immunology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 665
Number of Standardized 30-Day Fills 891.96666667
Aggregate Cost Paid for All Claims 868500.79
Number of Day's Supply for All Claims 24980
Number of Medicare Beneficiaries 117
Number of Claims, Including Refills, for Beneficiaries Age 65+ 541
Including Refills, for Beneficiaries Age 65+ 752.3
Beneficiaries Age 65+ 107676.98
Number of Day's Supply for All Claims for Beneficaries Age 65+ 21315
Number of Medicare Beneficiaries Age 65+ 100
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 242
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 423
Aggregate Cost Paid for Generic Drugs 164786.3
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 352
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 822245.37
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 313
Aggregate Cost Paid for Claims Filled by 46255.42
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 264
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 803144.41
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 401
by Low-Income Subsidy 65356.38
Total Claims of Opioid Drugs, Including 0
Aggregate Cost Paid for Opioid Drugs 0
Opioid Claims 0
Opioid_Tot_Clms divided by the Tot_Clms 0
Total Claims of Long-Acting Opioid Drugs 0
Aggregate Cost Paid for Long-Acting Opioid 0
Number of Day's Supply of All Long-Acting 0
Long-Acting Opioid Claims 0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including 19
Aggregate Cost Paid for Antibiotic Drugs 334.64
Antibiotic Claims 12
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims 0
Average Age of Beneficiaries 71.957264957
Number of Beneficiaries Age Less Than 65 17
Number of Beneficiaries Age 65 to 74 51
Number of Beneficiaries Age 75 to 84 35
Number of Female Beneficiaries 81
Number of Male Beneficiaries 36
Number of Non-Hispanic White 81
Number of Black or African American 33
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries 0
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not
Only Entitlement 87
Average Hierarchical Condition Category 1.0793019943

More Providers in bossier-city , la

Dr. peter Bryan boggs in Other Directories

Provider don't have other directory link yet.